Maximus review

What it is

A men's-health telehealth company selling testosterone in three exogenous routes — injectable, cream and oral, plus injectable with hCG — alongside a separate enclomiphene line in standalone and combination protocols, growth-hormone peptides in sermorelin and tesamorelin, compounded and branded GLP-1 medications, blood-flow and hair products, and lab panels running to 146 markers. The enclomiphene reputation it carries is out of date as a limitation: it now sells real exogenous testosterone across all three routes, and markets fertility-preserving combinations of testosterone with enclomiphene or hCG that most TRT providers do not offer at all.

How it works

Fully online with no in-person option, and asynchronous-first: complete an evaluation and intake, order an at-home lab test, have a licensed doctor finalise the prescription based on results, then monitor and adjust with 24/7 messaging. There is no mandatory scheduled video visit. Lab work is a real gate for testosterone — required to confirm eligibility, guide dosing and monitor markers over time, with an upload path if you have bloodwork from the last six months covering total testosterone, SHBG or free testosterone, LH, PSA and hematocrit. Pricing, side-effect tables and FAQs are all public with no signup gate, instalments are offered, and HSA and FSA are accepted. On disclosure Maximus is the standout: it publishes state availability per product rather than a blanket claim, notes that compounded GLP-1s are unavailable in three named states and sermorelin in one, and discloses that some peptide doses and vial sizes are smaller in California. Its LegitScript claim is made carefully and precisely — it says it partners exclusively with LegitScript-certified US pharmacies, a claim about the pharmacies rather than about itself, which is the correct way to phrase it. No individual clinician is named, however: the medical director is referenced but never identified.

Pricing transparency

An honest ladder, and one of the few in this batch where the month-to-month tier is real rather than notional. Injectable testosterone runs $199.99 a month month-to-month, $149.99 on three months and $99.99 on six; the cream $209.99 down to $109.99; oral testosterone $249.99 down to $149.99; injectable with hCG $399.99 down to $299.99; and growth-hormone peptides $299.99 down to $199.99 on six months. Because a genuine no-commitment price exists on every product, the cards here carry the month-to-month figure and describe the discounted tiers, rather than leading with a headline that requires a prepayment. Three cautions. A site-wide banner offers 50% off the first month for new customers buying a six-month plan — a promotional first month layered on a commitment, not a recurring rate. Injectable testosterone and enclomiphene both advertise "starting at $99.99", but injectable reaches it on six months and enclomiphene only on twelve, so the two headlines are not comparable. And the sermorelin page contradicts itself on cost per day: its hero claims "less than $6/day" while its closing call to action says "under $9/day", and the page's own $199.99 works out to $6.58 — so the hero is simply wrong. Every product page carries the honest footnote that pricing varies by dosage, plan length and state.

Branded vs compounded

Compounded; not FDA-approved — and Maximus discloses this at a level of specificity nothing else in this batch approaches. Its safety page states per product which items are compounded and which are approved, volunteers that enclomiphene is not FDA-approved as a standalone drug, explains that sermorelin was previously approved as Geref but has been discontinued so all current sermorelin is compounded, and notes that tesamorelin is approved as Egrifta for HIV-associated lipodystrophy but is a compounded formulation when dispensed for other indications. It cites FDA class labelling with dates and links manufacturer prescribing information. Its testosterone is real exogenous hormone but dispensed from FDA-registered 503A or 503B compounding pharmacies, with oral and cream formulations explicitly compounded and not FDA-approved as finished products. Two things to weigh against the marketing. The injectable page markets the formulation as free of seed oils while the safety page lists sesame-oil hypersensitivity among the contraindications, which implies a sesame-oil injectable in the line and contradicts the claim. And the efficacy figures quoted throughout — a mean doubling of total testosterone, a mean peak of 1,321 ng/dL, zero hepatic adverse events in an N=100 open-label study — come from the company's own self-published, uncontrolled whitepapers rather than peer-reviewed controlled trials, and should be read as company-reported. On the evidence, sermorelin and tesamorelin act on the growth-hormone axis with thin long-term human outcome data. Testosterone replacement has a large randomised safety base and still requires monitoring. Individual results vary.

Pros and watch-outs

The evidence behind what Maximus prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• Tesamorelin vs sermorelin: two GHRH analogs, very different status

  Both stimulate your own growth hormone. Only tesamorelin is FDA-approved (HIV visceral fat); sermorelin is the shorter, now-compounded option. Neither is proven anti-aging.

• TRT vs natural testosterone: what actually works?

  Losing excess weight and fixing short sleep genuinely raise testosterone; exercise helps mostly via fat loss; zinc and vitamin D only if you're deficient; and most 'boosters' don't work. When that isn't enough, TRT is.

• Low testosterone treatment: the stepwise options that actually work

  Confirm it's real, fix any reversible cause (weight, sleep, medications) first, then choose the medication — TRT for confirmed hypogonadism, enclomiphene or hCG when fertility matters.

• Testosterone levels by age: the real reference ranges, honestly explained

  There’s no official per-decade chart — labs use one adult reference range (harmonized to roughly 264–916 ng/dL in healthy young men). Levels do fall ~1%/year with age, but partly because of weight, not age alone — and a number is never a diagnosis.

How Maximus compares

A few alternatives worth a look, depending on what you’re optimizing for.

• OLOak Longevity

  Low-cost sermorelin within a broader longevity stack

  See Oak Longevity →
• HEHealthRX

  Compounded sermorelin within a broad longevity and weight-care menu

  See HealthRX →
• BHBodybuilding Health+

  Pairing sermorelin with a strength-training and recovery focus

  See Bodybuilding Health+ →